Roseburg, OR, United States
Hiers Enterprises, LLC dba Northwest Compounding Pharmacy recalls
1 recall recorded since 2018, most recently on 2 January 2019. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)0
Terminated Class II Drugs
- Recall started
- 2 January 2019
- Terminated
- 28 March 2023
- Reason
- Lack of sterility assurance.
- Distribution
- Product was distributed exclusively in the state of Oregon to 3 Medical facilities, 1 Physician's office and 80 consumers/patients. These are compounded products - labels vary for each compound - specific to each patient. Firm did not provide labeling.
- Initiated
- Voluntary: Firm initiated
- Recall numbers
- D-0400-2019, D-0397-2019, D-0396-2019, D-0407-2019, D-0399-2019, D-0408-2019, D-0395-2019, D-0401-2019, D-0392-2019, D-0405-2019, D-0406-2019, D-0402-2019 and 5 more
- Methocarbamol liquid 100mg/ml, RX, glass vial
- Lidocaine gel 2%, RX, plastic dropper
- Hydroxyprogesterone liquid, 250mg/ml, RX, glass vial
- Glutathione liquid, 200mg/ml, Rx
- MIC B vitamin liquid 25/50/50/1/1/1mg/ml RX glass vial
- Lidocaine gel 1%, RX, plastic dropper
- HCG liquid, 1000u/ml, RX, glass vial, various
- Testosteron Cypionate liquid 200mg/ml, RX, glass vial
- and 9 more product lines
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.